Expansion Opportunities Orbem is rapidly expanding from Munich to the United States, with recent office growth and a focus on scaling poultry solutions, food quality inspection, and healthcare verticals. This signals a greenfield opportunity to engage in US-based pilot projects, channel partnerships, and enterprise contracts with food producers, research labs, and healthcare institutions.

AI MRI Advantage The company leverages AI-powered MRI for non-invasive, rapid analyses of biological materials, including eggs, seeds, and fruits. This differentiator can be positioned to target Fortune 1000 food growers, seed companies, and biopharma/diagnostics labs seeking waste reduction, quality improvements, and transparency across supply chains.

Investment Momentum With a substantial Series B raise led by Innovation Industries and participation from Supernova Invest, Orbem is capitalized to scale and enter new verticals. Sales conversations can highlight accelerated product development timelines, larger deployment rounds, and long-term strategic partnerships with early adopters.

Genus Scale Rollout The launch of Genus Scale enables internal checks of fertilization status inside eggs, expanding from general MRI analyses to targeted breeding and hatchery optimization. This creates upsell opportunities with hatcheries, poultry integrators, and animal genetics labs seeking precise, non-destructive quality metrics.

Sustainability & Compliance Orbem emphasizes reducing waste, enhancing quality, and increasing transparency to support a more sustainable food system and healthier future. This aligns with ESG-focused procurement teams, regulatory-led food safety programs, and sustainability-driven RFPs, offering a compelling narrative for enterprise procurement cycles.